Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain

The Journal of Pain - Tập 17 Số 6 - Trang 739-744 - 2016
Kevin F. Boehnke1, Evangelos Litinas2, Daniel J. Clauw3,4
1Department of Environmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, Michigan
2Om of Medicine, Ann Arbor, Michigan.
3Chronic Pain and Fatigue Research Center, Medical School, University of Michigan, Ann Arbor, Michigan
4Departments of Anesthesiology, Medicine (Rheumatology), and Psychiatry, Medical School, University of Michigan, Ann Arbor, Michigan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Arnold, 2012, A framework for fibromyalgia management for primary care providers, Mayo Clin Proc, 87, 488, 10.1016/j.mayocp.2012.02.010

Bachhuber, 2014, Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010, JAMA Intern Med, 19104, 1

Brummett, 2013, Survey criteria for fibromyalgia independently predict increased postoperative opioid consumption after lower-extremity joint arthroplasty, Anesthesiology, 119, 1434, 10.1097/ALN.0b013e3182a8eb1f

Clauw, 2014, Fibromyalgia: A clinical review, JAMA, 311, 1547, 10.1001/jama.2014.3266

Degenhardt, 2015, Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study, Drug Alcohol Depend, 147, 144, 10.1016/j.drugalcdep.2014.11.031

Farrell, 2014, Should doctors prescribe cannabinoids?, BMJ, 348, g2737, 10.1136/bmj.g2737

Hazekamp, 2013, The prevalence and incidence of medicinal cannabis on prescription in the Netherlands, Eur J Clin Pharmacol, 69, 1575, 10.1007/s00228-013-1503-y

2011

Janda, 2015, Fibromyalgia survey criteria are associated with increased postoperative opioid consumption in women undergoing hysterectomy, Anesthesiology, 122, 1103, 10.1097/ALN.0000000000000637

Jones, 2013, Pharmaceutical overdose deaths, United States, 2010, JAMA, 309, 657, 10.1001/jama.2013.272

LARA. Department of Licensing and Regulatory Affairs: MAPS Statistics. Available at: http://www.michigan.gov/lara/0,4601,7-154-72600_72603_55478_55484---,00.html

Leung, 2011, Cannabis and its derivatives: Review of medical use, J Am Board Fam Med, 24, 452, 10.3122/jabfm.2011.04.100280

Lynch, 2011, Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials, Br J Clin Pharmacol, 72, 735, 10.1111/j.1365-2125.2011.03970.x

Phillips, 2013, Central pain mechanisms in the rheumatic diseases: Future directions, Arthritis Rheum, 65, 291, 10.1002/art.37739

Whiting, 2015, Cannabinoids for medical use, JAMA, 313, 2456, 10.1001/jama.2015.6358

Wolfe, 2011, Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia, J Rheumatol, 38, 1113, 10.3899/jrheum.100594

Advisory Committee on Pain and Symptom Management: 2014: The “state” of pain in Michigan. Available at: https://www.michigan.gov/documents/lara/ACPSM_State_of_Pain_Report_to_Directors_Sept._2014_469555_7.pdf